Search

Author/Creator Yu, H.

2. 2572 Clinical and translational assessment of VEGFR1 as a mediator of the pre-metastatic niche: Neoadjuvant axitinib in high-risk localized prostate cancer. (September 2015)

Authors:
Pal, S.; Vuong, W.; Zhang, W.; Deng, J.; Liu, X.; Ruel, N.; Pinnamaneni, M.; Twardowski, P.; Lau, C.; Yu, H.; Figlin, R.; Agarwal, N.; Jones, J.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S501
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. 2925 Expression of the Epithelial-Mesenchymal-Transition (EMT) markers, Twist, Slug, Snail, E- and N-cadherins and the association with clinical and pathological features of human pituitary adenomas. (September 2015)

Authors:
Jia, W.; Zhu, J.; Martin, T.A.; Sanders, A.J.; Yang, X.; Cheng, S.; Yu, H.; Jia, G.; Jiang, W.G.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S592
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. 3009 Activity of rociletinib in EGFR mutant NSCLC patients with a history of CNS involvement. (September 2015)

Authors:
Varga, A.; Camidge, D.R.; Sequist, L.V.; Wakelee, H.; Ou, S.H.; Goldman, J.W.; Papadimitrakopoulou, V.; Gadgeel, S.; Mekhail, T.; Oxnard, G.R.; Socinski, M.; Solomon, B.; Yu, H.; Matheny, S.; Despain, D.; Soria, J.C.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S598
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. 3088 Efficacy of rociletinib (co-1686) in EGFR-mutant non-small cell lung cancer (NSCLC) patients (pts) assessed with a plasma EGFR test. (September 2015)

Authors:
Gadgeel, S.; Soria, J.C.; Goldman, J.W.; Wakelee, H.; Camidge, D.R.; Yu, H.; Varga, A.; Solomon, B.; Oxnard, G.R.; Ou, S.H.; Papadimitrakopoulou, V.; Liu, S.V.; Reckamp, K.; Spira, A.; Piotrowska, Z.; Despain, D.; Karlovich, C.; Yurasov, S.; Sequist, L.V.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S628
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. 3104 Rociletinib treatment and outcomes in non-small cell lung cancer (NSCLC) patients with negative central testing for T790M. (September 2015)

Authors:
Solomon, B.; Wakelee, H.; Sequist, L.V.; Gadgeel, S.; Soria, J.C.; Goldman, J.W.; Yu, H.; Camidge, D.R.; Papadimitrakopoulou, V.; Matheny, S.; Despain, D.; Besse, B.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S636
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. 3105 Dose optimization of rociletinib for EGFR mutated NSCLC: Benefit/risk analysis from the TIGER-X trial. (September 2015)

Authors:
Soria, J.C.; Goldman, J.W.; Wakelee, H.; Gadgeel, S.; Camidge, D.R.; Solomon, B.; Yu, H.; Oxnard, G.R.; Ou, S.H.; Papadimitrakopoulou, V.; Perol, M.; Reckamp, K.; Varga, A.; Dziadziuszko, R.; Chouaid, C.; Cortot, A.; Do, P.; Moro-Sibilot, D.; Poudenx, M.; Sequist, L.V.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S637
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗